Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
344.6 USD | +4.11% | +3.61% | +15.08% |
May. 30 | JPMorgan Adjusts Price Target on Cigna to $435 From $432 | MT |
May. 30 | Baird Initiates Cigna at Outperform Rating With $388 Price Target | MT |
Financials (USD)
Sales 2024 * | 236B | Sales 2025 * | 247B | Capitalization | 97.9B |
---|---|---|---|---|---|
Net income 2024 * | 5B | Net income 2025 * | 7.14B | EV / Sales 2024 * | 0.51 x |
Net Debt 2024 * | 23.07B | Net Debt 2025 * | 19.52B | EV / Sales 2025 * | 0.48 x |
P/E ratio 2024 * |
18.5
x | P/E ratio 2025 * |
13.1
x | Employees | 71,413 |
Yield 2024 * |
1.62% | Yield 2025 * |
1.74% | Free-Float | 69.59% |
Latest transcript on Cigna
1 day | +4.11% | ||
1 week | +3.61% | ||
1 month | -3.48% | ||
3 months | +2.52% | ||
6 months | +31.09% | ||
Current year | +15.08% |
Managers | Title | Age | Since |
---|---|---|---|
David Cordani
CEO | Chief Executive Officer | 58 | 90-12-31 |
Brian Evanko
DFI | Director of Finance/CFO | 48 | - |
Paul Sanford
COO | Chief Operating Officer | - | 21-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 17-12-31 | |
David Cordani
CEO | Chief Executive Officer | 58 | 90-12-31 |
Donna Zarcone
BRD | Director/Board Member | 66 | 04-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.33% | 8 M€ | -.--% | ||
2.28% | 17 M€ | +6.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 344.6 | +4.11% | 3,915,510 |
24-05-30 | 331 | -0.58% | 3,686,558 |
24-05-29 | 332.9 | -0.09% | 2,931,143 |
24-05-28 | 333.2 | +0.18% | 1,445,841 |
24-05-24 | 332.6 | -1.55% | 1,311,594 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.08% | 97.9B | |
+14.19% | 125B | |
-21.78% | 43.15B | |
-3.53% | 38.2B | |
-12.93% | 18.43B | |
-27.51% | 2.57B | |
-8.59% | 1.5B | |
+15.53% | 546M |
- Stock Market
- Equities
- CI Stock